SPLENOMEGALY
Clinical trials for SPLENOMEGALY explained in plain language.
Never miss a new study
Get alerted when new SPLENOMEGALY trials appear
Sign up with your email to follow new studies for SPLENOMEGALY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to shrink spleen and boost transplant success in myelofibrosis
Disease control Recruiting nowThis study tests whether giving high-dose ruxolitinib and busulfan before a stem cell transplant can reduce spleen size and help the transplant work better in people with myelofibrosis. About 30 adults aged 18 to 75 with an enlarged spleen and a matched donor will take part. The …
Matched conditions: SPLENOMEGALY
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for rare blood disorder: drug targets overactive immune cells
Disease control Recruiting nowThis phase 2 trial is testing the drug ruxolitinib in people with hypereosinophilic syndrome, a rare condition where the body produces too many eosinophils (a type of white blood cell), causing organ damage. The study aims to see if ruxolitinib can normalize blood cell counts and…
Matched conditions: SPLENOMEGALY
Phase: PHASE2 • Sponsor: William Shomali • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC